Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Neurosurgical Focus|August 1, 2025
The role of extent of resection, chemoradiation, and MGMT promoter methylation in overall survival in a large cohort of IDH-wildtype glioblastomaMegan Parker, Austin Carmichael, Antolin Serrano-Farias, et al.
Expert Review of Anticancer Therapy|June 24, 2026
The dual role of Schlafen11 in brain tumors: Jekyll and HydeManabu Natsumeda, Masayasu Okada, Satoshi Nakata, et al.
Journal of Neurological Surgery. Part B, Skull Base|February 9, 2019
Surgical Outcomes, Complications, and Management Strategies for Foramen Magnum MeningiomasStephen T Magill, Maryam N Shahin, Calixto-Hope G Lucas, et al.
The American Journal of Surgical Pathology|January 14, 2025
Increased SOX10, p16, and Cyclin D1 Immunoreactivity Differentiates MAP Kinase-activated Low-grade Gliomas From Piloid GliosisVivian Tang, Kevin Y Zhang, Kanish Mirchia, et al.
Journal of Neuro-Oncology|October 31, 2022
Radiotherapy for meningiomasWilliam C Chen, Haley K Perlow, Abrar Choudhury, et al.
International Journal of Molecular Sciences|September 9, 2023
Management and Molecular Characterization of Intraventricular Glioblastoma: A Single-Institution Case SeriesMegan Parker, Anita Kalluri, Joshua Materi, et al.
Neuro-Oncology Advances|September 3, 2025
Combined inhibition of SHP2 overcomes adaptive resistance to type 1 BRAF inhibitors in BRAF V600E-driven high-grade gliomaAbiola A Ayanlaja, Michael Chang, Kriti Lalwani, et al.
Neurosurgical Focus|April 3, 2018
Tuberculum sellae meningiomas: grading scale to assess surgical outcomes using the transcranial versus transsphenoidal approachStephen T Magill, Ramin A Morshed, Calixto-Hope G Lucas, et al.
Pageof 8